News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
146,779 Results
Type
Article (5907)
Company Profile (5)
Press Release (140867)
Multimedia
Podcasts (18)
Webinars (5)
Section
Business (53322)
Career Advice (142)
Deals (14386)
Drug Delivery (26)
Drug Development (11960)
Employer Resources (21)
FDA (1517)
Job Trends (2709)
News (78259)
Policy (3708)
Tag
2027 Pharm Country Standard (1)
Academia (213)
Accelerated approval (10)
Allergies (25)
Alliances (7223)
ALS (36)
Alzheimer's disease (225)
Antibody-drug conjugate (ADC) (63)
Approvals (1526)
Artificial intelligence (122)
Autoimmune disease (35)
Automation (4)
Bankruptcy (134)
Best Places to Work (1981)
BIOSECURE Act (3)
Biosimilars (32)
Biotechnology (12)
Bladder cancer (19)
Brain cancer (13)
Breast cancer (82)
Cancer (851)
Cardiovascular disease (93)
Career advice (131)
Career pathing (3)
CAR-T (60)
CDC (12)
Cell therapy (189)
Cervical cancer (7)
Clinical research (10745)
Collaboration (287)
Company closure (3)
Compensation (80)
Complete response letters (13)
COVID-19 (294)
CRISPR (18)
C-suite (307)
Cystic fibrosis (29)
Data (1237)
Denatured (10)
Depression (30)
Diabetes (116)
Diagnostics (1370)
Digital health (10)
Diversity (2)
Diversity, equity & inclusion (7)
Drug discovery (59)
Drug pricing (50)
Drug shortages (7)
Duchenne muscular dystrophy (61)
Earnings (32361)
Editorial (30)
Employer branding (5)
Employer resources (19)
Events (16770)
Executive appointments (368)
FDA (2246)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (12)
Funding (896)
Gene editing (56)
Generative AI (10)
Gene therapy (175)
GLP-1 (247)
Government (349)
Guidances (279)
Healthcare (3671)
HIV (13)
Huntington's disease (8)
IgA nephropathy (16)
Immunology and inflammation (81)
Immuno-oncology (15)
Indications (11)
Infectious disease (343)
Inflammatory bowel disease (36)
Inflation Reduction Act (6)
Influenza (19)
Intellectual property (84)
Interviews (17)
IPO (8720)
IRA (13)
Job creations (743)
Job search strategy (115)
JPM (32)
Kidney cancer (5)
Labor market (21)
Layoffs (117)
Leadership (7)
Legal (735)
Liver cancer (18)
Longevity (2)
Lung cancer (112)
Lymphoma (57)
Machine learning (13)
Management (5)
Manufacturing (230)
MASH (74)
Medical device (3463)
Medtech (3477)
Mergers & acquisitions (6309)
Metabolic disorders (399)
Multiple sclerosis (25)
NASH (7)
Neurodegenerative disease (71)
Neuropsychiatric disorders (31)
Neuroscience (492)
Neurotech (1)
NextGen: Class of 2026 (1454)
Non-profit (331)
Now hiring (5)
Obesity (210)
Opinion (69)
Ovarian cancer (16)
Pain (53)
Pancreatic cancer (67)
Parkinson's disease (41)
Partnered (7)
Patents (129)
Patient recruitment (114)
Peanut (13)
People (13971)
Pharmaceutical (5)
Pharmacy benefit managers (5)
Phase 1 (3460)
Phase 2 (5178)
Phase 3 (3190)
Pipeline (2201)
Policy (63)
Postmarket research (155)
Preclinical (1456)
Press Release (8)
Prostate cancer (42)
Psychedelics (10)
Radiopharmaceuticals (83)
Rare diseases (182)
Real estate (1017)
Recruiting (8)
Regulatory (3327)
Reports (7)
Research institute (228)
Resumes & cover letters (22)
Rett syndrome (6)
RNA editing (5)
RSV (9)
Schizophrenia (43)
Series A (185)
Series B (149)
Service/supplier (1)
Sickle cell disease (22)
Special edition (3)
Spinal muscular atrophy (8)
Sponsored (4)
Startups (2109)
State (1)
Stomach cancer (1)
Supply chain (23)
Tariffs (30)
The Weekly (8)
Vaccines (132)
Venture capital (86)
Weight loss (144)
Women's health (29)
Worklife (1)
Date
Last 7 days (129)
Last 30 days (575)
Last 365 days (9162)
2026 (776)
2025 (9254)
2024 (10305)
2023 (11406)
2022 (12136)
2021 (13510)
2020 (12326)
2019 (9211)
2018 (6754)
2017 (7238)
2016 (5556)
2015 (7517)
2014 (5447)
2013 (3788)
2012 (4077)
2011 (4488)
2010 (4137)
Location
Africa (109)
Alabama (22)
Alaska (2)
Arizona (59)
Arkansas (2)
Asia (8735)
Australia (1464)
California (3326)
Canada (1269)
China (195)
Colorado (176)
Connecticut (230)
Delaware (57)
Europe (18066)
Florida (518)
Georgia (116)
Hawaii (2)
Idaho (12)
Illinois (164)
India (16)
Indiana (140)
Iowa (3)
Japan (47)
Kansas (31)
Kentucky (5)
Louisiana (10)
Maine (23)
Maryland (312)
Massachusetts (2124)
Michigan (174)
Minnesota (204)
Mississippi (2)
Missouri (27)
Montana (5)
Nebraska (4)
Nevada (61)
New Hampshire (22)
New Jersey (795)
New Mexico (5)
New York (995)
North Carolina (429)
North Dakota (1)
Northern California (1487)
Ohio (67)
Oklahoma (4)
Oregon (8)
Pennsylvania (731)
Puerto Rico (4)
Rhode Island (12)
South America (202)
South Carolina (5)
Southern California (1446)
Tennessee (41)
Texas (640)
United States (11634)
Utah (84)
Virginia (126)
Washington D.C. (11)
Washington State (301)
West Virginia (3)
Wisconsin (18)
Wyoming (2)
146,779 Results for "behrman capital".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Spruce Biosciences Secures Up to $50 Million in Growth Capital from Avenue Capital
January 8, 2026
·
5 min read
Press Releases
Vor Bio Appoints RA Capital’s Andrew Levin, M.D., Ph.D., and Forbion’s Wouter Joustra to Board of Directors
December 24, 2025
·
3 min read
Insights
JPM26: As Capital Concentrates, VCs Scrutinize Founder Pedigree and CEO Fit in Early Biotech
Venture funds attending the J.P. Morgan Healthcare Conference said mounting funding pressures and Chinese competition have sharpened their focus on leadership qualities, from regulatory expertise and industry experience to the ability to scale—or step aside—as companies mature.
January 15, 2026
·
2 min read
·
Jennifer Smith-Parker
Press Releases
Poxel Announces the Implementation of an Equity Line With IRIS Capital as Part of the Execution of the Recovery Plan
February 3, 2026
·
12 min read
Press Releases
enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc.
January 21, 2026
·
10 min read
Press Releases
Vyome Successfully Capitalizes All VT-1953 Funding Requirements For Initial Phase 3 Results
February 2, 2026
·
4 min read
Press Releases
Humacyte Announces Credit Facility of Up to $77.5 Million with Avenue Capital
December 17, 2025
·
6 min read
Press Releases
NurExone Appoints Eyal Gabbai to Board, Adding Large-Scale Healthcare System and Capital Markets Expertise
February 2, 2026
·
6 min read
Press Releases
Turbett Surgical Announces Recapitalization and Growth Investment by J.P. Morgan Life Sciences Private Capital
January 28, 2026
·
3 min read
Press Releases
Interpace Biosciences Announces Preliminary 2025 Revenue, 2026 Revenue Guidance and Simplification of Capital Structure
January 21, 2026
·
6 min read
1 of 14,678
Next
